UBS Group’s BlackRock Future Health ETF BMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $16.4K | Buy |
537
+536
| +53,600% | +$15.3K | ﹤0.01% | 8278 |
|
|
2026
Q1 | $29 | Hold |
1
| – | – | ﹤0.01% | 10257 |
|
|
2025
Q4 | $30 | Hold |
1
| – | – | ﹤0.01% | 10321 |
|
|
2025
Q3 | $27 | Hold |
1
| – | – | ﹤0.01% | 10090 |
|
|
2025
Q2 | $25 | Hold |
1
| – | – | ﹤0.01% | 10105 |
|
|
2025
Q1 | $24 | Sell |
1
-400
| -100% | -$10.2K | ﹤0.01% | 10072 |
|
|
2024
Q4 | $9.98K | Buy |
+401
| New | +$10.3K | ﹤0.01% | 8326 |
|
|
2024
Q3 | – | Sell |
-85
| Closed | -$2.13K | – | 9513 |
|
|
2024
Q2 | $2.13K | Buy |
85
+12
| +16% | +$300 | ﹤0.01% | 8423 |
|
|
2024
Q1 | $1.93K | Buy |
+73
| New | +$1.86K | ﹤0.01% | 8019 |
|
|
2023
Q3 | – | Sell |
-499
| Closed | -$12.4K | – | 9477 |
|
|
2023
Q2 | $12.4K | Buy |
+499
| New | +$12.1K | ﹤0.01% | 7079 |
|
|
2023
Q1 | – | Sell |
-421
| Closed | -$9.77K | – | 9629 |
|
|
2022
Q4 | $9.77K | Buy |
421
+108
| +35% | +$2.43K | ﹤0.01% | 8614 |
|
|
2022
Q3 | $7K | Sell |
313
-105
| -25% | -$2.38K | ﹤0.01% | 8849 |
|
|
2022
Q2 | $9K | Sell |
418
-584
| -58% | -$13.5K | ﹤0.01% | 8115 |
|
|
2022
Q1 | $25K | Sell |
1,002
-162
| -14% | -$4.08K | ﹤0.01% | 7179 |
|
|
2021
Q4 | $34K | Buy |
1,164
+31
| +3% | +$894 | ﹤0.01% | 7253 |
|
|
2021
Q3 | $33K | Buy |
1,133
+468
| +70% | +$14.1K | ﹤0.01% | 6660 |
|
|
2021
Q2 | $20K | Sell |
665
-95
| -13% | -$2.77K | ﹤0.01% | 7320 |
|
|
2021
Q1 | $21K | Buy |
+760
| New | +$22.8K | ﹤0.01% | 7329 |
|
Other funds holding BMED
UBS Group's BMED Position: Q2 2026 in Review
UBS Group increased its BlackRock Future Health ETF (BMED) stake by 53,600% in Q2 2026, buying an estimated $15.3K and bringing the position to 537 shares worth $16.4K. The position accounts for ﹤0.01% of the portfolio, ranked #8278.
UBS Group first reported a position in BMED in Q1 2021 and has held it in 18 quarters since. The position peaked at $34K in Q4 2021. 3 funds tracked by Wall St. Rank hold BMED as of Q2 2026.
- UBS Group held 537 shares of BlackRock Future Health ETF worth $16.4K as of Q2 2026.
- UBS Group bought 536 BlackRock Future Health ETF shares in Q2 2026, an estimated $15.3K.
- BlackRock Future Health ETF made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8278 holding.
- UBS Group first reported a position in BlackRock Future Health ETF in Q1 2021 and has held it in 18 quarters since.
- UBS Group's BlackRock Future Health ETF position peaked at $34K in Q4 2021.
- 3 funds tracked by Wall St. Rank held BlackRock Future Health ETF as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.